Genix Pharmaceuticals Corporation (GENPF)

Genix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	1	2	2	3	7	7
Market Cap Growth	-88.70%	24.59%	-39.58%	-60.60%	-2.74%	269.14%
Enterprise Value	2	3	2	3	7	7
Last Close Price	0.01	0.04	0.03	0.01	0.12	-
PS Ratio	18315.34	730.98	191.87	-	-	-
PB Ratio	-0.87	-2.50	-2.08	1.20	2.21	2.02
P/TBV Ratio	-	-	-	-	-	43.40
EV/Sales Ratio	-	910.96	225.59	-	-	-
EV/EBITDA Ratio	10.83	20.25	-	-	-	-
Debt / Equity Ratio	-0.72	-0.69	-0.45	0.06	0.01	0.00
Debt / EBITDA Ratio	4.94	4.48	-	-	-	-
Net Debt / Equity Ratio	-0.71	-0.68	-0.44	0.05	-0.02	-0.14
Net Debt / EBITDA Ratio	4.92	4.41	-1.75	-0.38	0.08	2.15
Net Debt / FCF Ratio	-7.63	-4.29	-2.26	-0.79	0.21	3.49
Asset Turnover	0.00	0.03	0.01	-	-	-
Inventory Turnover	-	-	0.06	-	-	-
Quick Ratio	0.00	0.01	0.01	0.02	0.19	2.01
Current Ratio	0.02	0.03	0.16	0.23	0.25	2.05
Return on Equity (ROE)	-	-	-426.41%	-29.78%	-37.25%	-29.85%
Return on Assets (ROA)	-163.17%	-169.16%	-23.23%	-13.83%	-19.90%	-15.75%
Return on Capital Employed (ROCE)	23.80%	30.80%	73.10%	-31.20%	-40.00%	-13.60%
Earnings Yield	-7.15%	-2.47%	-185.55%	-27.90%	-18.60%	-7.33%
FCF Yield	-	-6.33%	-9.31%	-5.70%	-4.82%	-1.99%
Buyback Yield / Dilution	-	-	-	-	-18.55%	-33.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.